Urokinase infusion: feasibility of monitoring for complications in a non-intensive care setting.

W. D. Routh, C. M. Tatum, Robert Barton, G. M. Gross, H. A. McDowell, Frederick Keller

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

In an effort to more effectively use critical care facilities and to reduce costs, during a 2 1/2-year period, the condition of 32 patients who received 37 local intraarterial urokinase (UK) infusions was monitored in a non-intensive care unit (ICU) setting. Techniques of infusion, mean total dose of lytic agent used (1.7 million IU), and mean duration of infusion (22 hours) were similar to those reported previously in series of patients monitored in the ICU. Complete lysis (no angiographically detectable residual clot within the treated segment) was achieved in 28 of 37 infusions (76%). Major complications occurred during two infusions (5.4%). In 33 of the 37 cases, systemic heparin was administered during UK infusion. No cases of pericatheter thrombosis were encountered. At the authors' institution, patients can be safely monitored during local UK infusion in a non-ICU setting without compromising effectiveness of therapy. This approach has resulted in enhanced cost-effectiveness of thrombolytic therapy and more effective use of critical care facilities.

Original languageEnglish (US)
Pages (from-to)69-72
Number of pages4
JournalJournal of vascular and interventional radiology : JVIR
Volume2
Issue number1
StatePublished - Feb 1991
Externally publishedYes

Fingerprint

Urokinase-Type Plasminogen Activator
Critical Care
Intra Arterial Infusions
Thrombolytic Therapy
Cost-Benefit Analysis
Intensive Care Units
Heparin
Thrombosis
Costs and Cost Analysis
Therapeutics

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Urokinase infusion : feasibility of monitoring for complications in a non-intensive care setting. / Routh, W. D.; Tatum, C. M.; Barton, Robert; Gross, G. M.; McDowell, H. A.; Keller, Frederick.

In: Journal of vascular and interventional radiology : JVIR, Vol. 2, No. 1, 02.1991, p. 69-72.

Research output: Contribution to journalArticle

@article{c812407228884ce1bdb2d4b43d382f60,
title = "Urokinase infusion: feasibility of monitoring for complications in a non-intensive care setting.",
abstract = "In an effort to more effectively use critical care facilities and to reduce costs, during a 2 1/2-year period, the condition of 32 patients who received 37 local intraarterial urokinase (UK) infusions was monitored in a non-intensive care unit (ICU) setting. Techniques of infusion, mean total dose of lytic agent used (1.7 million IU), and mean duration of infusion (22 hours) were similar to those reported previously in series of patients monitored in the ICU. Complete lysis (no angiographically detectable residual clot within the treated segment) was achieved in 28 of 37 infusions (76{\%}). Major complications occurred during two infusions (5.4{\%}). In 33 of the 37 cases, systemic heparin was administered during UK infusion. No cases of pericatheter thrombosis were encountered. At the authors' institution, patients can be safely monitored during local UK infusion in a non-ICU setting without compromising effectiveness of therapy. This approach has resulted in enhanced cost-effectiveness of thrombolytic therapy and more effective use of critical care facilities.",
author = "Routh, {W. D.} and Tatum, {C. M.} and Robert Barton and Gross, {G. M.} and McDowell, {H. A.} and Frederick Keller",
year = "1991",
month = "2",
language = "English (US)",
volume = "2",
pages = "69--72",
journal = "Journal of Vascular and Interventional Radiology",
issn = "1051-0443",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Urokinase infusion

T2 - feasibility of monitoring for complications in a non-intensive care setting.

AU - Routh, W. D.

AU - Tatum, C. M.

AU - Barton, Robert

AU - Gross, G. M.

AU - McDowell, H. A.

AU - Keller, Frederick

PY - 1991/2

Y1 - 1991/2

N2 - In an effort to more effectively use critical care facilities and to reduce costs, during a 2 1/2-year period, the condition of 32 patients who received 37 local intraarterial urokinase (UK) infusions was monitored in a non-intensive care unit (ICU) setting. Techniques of infusion, mean total dose of lytic agent used (1.7 million IU), and mean duration of infusion (22 hours) were similar to those reported previously in series of patients monitored in the ICU. Complete lysis (no angiographically detectable residual clot within the treated segment) was achieved in 28 of 37 infusions (76%). Major complications occurred during two infusions (5.4%). In 33 of the 37 cases, systemic heparin was administered during UK infusion. No cases of pericatheter thrombosis were encountered. At the authors' institution, patients can be safely monitored during local UK infusion in a non-ICU setting without compromising effectiveness of therapy. This approach has resulted in enhanced cost-effectiveness of thrombolytic therapy and more effective use of critical care facilities.

AB - In an effort to more effectively use critical care facilities and to reduce costs, during a 2 1/2-year period, the condition of 32 patients who received 37 local intraarterial urokinase (UK) infusions was monitored in a non-intensive care unit (ICU) setting. Techniques of infusion, mean total dose of lytic agent used (1.7 million IU), and mean duration of infusion (22 hours) were similar to those reported previously in series of patients monitored in the ICU. Complete lysis (no angiographically detectable residual clot within the treated segment) was achieved in 28 of 37 infusions (76%). Major complications occurred during two infusions (5.4%). In 33 of the 37 cases, systemic heparin was administered during UK infusion. No cases of pericatheter thrombosis were encountered. At the authors' institution, patients can be safely monitored during local UK infusion in a non-ICU setting without compromising effectiveness of therapy. This approach has resulted in enhanced cost-effectiveness of thrombolytic therapy and more effective use of critical care facilities.

UR - http://www.scopus.com/inward/record.url?scp=0026102508&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026102508&partnerID=8YFLogxK

M3 - Article

C2 - 1799750

AN - SCOPUS:0026102508

VL - 2

SP - 69

EP - 72

JO - Journal of Vascular and Interventional Radiology

JF - Journal of Vascular and Interventional Radiology

SN - 1051-0443

IS - 1

ER -